正电子发射断层显像衍生左心室质量的增量预后价值
研究纳入2357例因疑似或确诊冠状动脉疾病行PET心肌灌注显像的连续患者,评估PET衍生左心室质量(LVM)在临床变量和心肌血流储备(MFR)之上的增量预后价值。平均随访11.6±6.6个月,141例(6.0%)发生主要不良心血管事件(MACE)。在多变量Cox模型中,LVM与结局无独立关联(HR 1.00,P=.157),在MFR和临床变量之上无增量预后价值(C指数0.75,P=.571)。
要点
- PET衍生左心室质量与MACE无独立关联(HR 1.00,P=.157)。
- LVM在MFR和临床变量之上无增量预后价值(C指数0.75,P=.571)。
- 平均随访11.6±6.6个月,2357例中141例(6.0%)发生MACE。
核心结论
- PET衍生左心室质量在心肌血流储备和临床变量之上不提供独立及增量预后价值。
研究设计与样本
- 纳入连续患者,均因疑似或确诊冠状动脉疾病有临床指征行PET心肌灌注显像,从PET显像日期起随访MACE(包括全因死亡、非致死性心肌梗死及显像后90天经皮冠状动脉介入治疗/冠状动脉旁路移植术)。
- 共2357例患者,47%女性,平均年龄66±12岁,87%高血压,47%糖尿病,79%血脂异常。
主要发现
- 平均随访11.6±6.6个月,141例(6.0%,每1000人年5.1例)发生MACE(86例死亡/24例心肌梗死/39例经皮冠状动脉介入治疗/9例冠状动脉旁路移植术)。
- 在嵌套多变量Cox模型中,LVM与结局无独立关联(HR 1.00,P=.157)。
- LVM在MFR和临床变量之上无增量预后价值(C指数0.75,P=.571)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Left ventricular hypertrophy has been shown to be an independent predictor of outcomes in patients with coronary artery disease (CAD). We aimed to determine the incremental prognostic value of positron emission tomography (PET) derived left ventricular mass (LVM) to clinical variables and myocardial flow reserve (MFR). METHODS: We included consecutive patients who had clinically indicated PET myocardial perfusion imaging for suspected or established CAD. Patients were followed from the date of PET imaging for major adverse cardiovascular events (MACE, inclusive of all-cause death, non-fatal myocardial infarction, and percutaneous coronary intervention/coronary artery bypass grafting 90 days after imaging). RESULTS: A total of 2357 patients underwent PET MPI during the study period (47% female, mean age 66 ± 12 years, 87% hypertensive, 47% diabetic, 79% dyslipidemia). After a mean follow-up of 11.6 ± 6.6 months, 141 patients (6.0%, 5.1 per 1000 person-year) experienced MACE (86 D/24 MI/39 PCI/9 CABG). In nested multivariable Cox models, LVM was not independently associated with outcomes (HR 1.00, P = .157) and had no incremental prognostic value (C index: 0.75, P = .571) over MFR and clinical variables. CONCLUSION: Our analysis shows that LVM provides no independent and incremental prognostic value over MFR and clinical variables.
引用
- Ahmed AI, Saad JM, Han Y, et al. Incremental prognostic value of positron emission tomography derived left ventricular mass. J Nucl Cardiol. 2022. PMID: 35794457. doi:10.1007/s12350-022-03035-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。